Dermacyd PH_DETINLYN (Lactic Acid) Sweet Flower - Compatibility
Study Details
Study Description
Brief Summary
To demonstrate the absence of irritation potential (primary dermical irritability and cumulated dermical irritability) and allergy (sensibilization) of the product Dermacyd PHDETINLYN Sweet Flower.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 3 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: 1 Dermacyd PH_DETINLYN (Lactic Acid) |
Drug: Dermacyd PH_DETINLYN (Lactic Acid)
|
Outcome Measures
Primary Outcome Measures
- The absence of primary and accumulated dermical irritability and dermical sensitivity will be evaluated using International Contact Dermatitis Research Group (ICDRG) scale. [Throughout the study]
Eligibility Criteria
Criteria
Inclusion criteria:
-
Phototype Skin I,II, III e IV
-
Integral skin test in the region;
-
Willingness in following the study procedures and to be present in the clinic at the days and scheduled time for medical evaluations and for application of occlusion;
Exclusion criteria:
-
Lactation or gestation
-
Use of Antiinflammatory and/or immunossupression drugs
-
Personnel history of atopy
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
-
History of sensitivity or irritation for topic products;
-
Active cutaneous disease;
-
Use of new drugs or cosmetics during the study The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Sanofi-Aventis Administrative Office | Sao Paulo | Brazil |
Sponsors and Collaborators
- Sanofi
Investigators
- Study Director: Jaderson Lima, Sanofi
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- LACAC_L_04299